Show simple item record

dc.contributor.authorSolomon, David
dc.contributor.authorGrierson, Jeffrey
dc.contributor.authorGodier-McBard, Lauren
dc.contributor.authorGuirguis, Amira
dc.date.accessioned2023-10-19T09:28:04Z
dc.date.available2023-10-16T00:00:00Z
dc.date.available2023-10-19T09:28:04Z
dc.date.issued2023-10-16
dc.identifier.citationSolomon D, Grierson J, Godier-McBard L, Guirguis A (2023) 'Experience and views of healthcare professionals towards people who use new psychoactive substances: evidence from statutory, non-statutory, and private mental health and addiction healthcare services', Human Psychopharmacology: Clinical and Experimental, 38 (6), e2883en_US
dc.identifier.issn0885-6222
dc.identifier.pmid37843432
dc.identifier.doi10.1002/hup.2883
dc.identifier.urihttp://hdl.handle.net/10547/626023
dc.description.abstractIt is unclear how healthcare professionals (HCPs) experience and view the challenges of working with people who use New Psychoactive Substances (PWUNPS), in different healthcare services (HCS). The aim of the study was to explore HCPs' experiences of working with individuals who use NPS across statutory, non-statutory, and private mental health and addiction HCSs. HCPs completed in-depth semi-structured interviews. Audio recordings were transcribed verbatim with a mean duration of 30 min 55 s. Data were analysed through thematic analysis. A purposive sample of 14 HCPs (6 men, 8 women) with a mean age of 42.5 years were interviewed in 2019. Organisational issues, including funding, impacted the treatment for PWUNPS and HCPs perceived a lack of support dependent on their qualifications. They reported a lack of assessment, policy, harm reduction, and awareness of NPS-related symptoms including mental health problems and stigma faced by PWUNPS. HCPs need better training, education, and assessment processes to manage acute NPS intoxications and address the stigma associated with PWUNPS. There is a need for policy-making opportunities across different HCSs to ensure better healthcare outcomes for PWUNPS.en_US
dc.description.sponsorshipNo funding or grants were provided to conduct this studyen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.urlhttps://onlinelibrary.wiley.com/doi/10.1002/hup.2883en_US
dc.rightsYellow - can archive pre-print (ie pre-refereeing)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectexperiencesen_US
dc.subjecthealthcare professionalsen_US
dc.subjecthealthcare servicesen_US
dc.subjectnew psychoactive substancesen_US
dc.subjectSubject Categories::L510 Health & Welfareen_US
dc.titleExperience and views of healthcare professionals towards people who use new psychoactive substances: evidence from statutory, non-statutory, and private mental health and addiction healthcare servicesen_US
dc.typeArticleen_US
dc.identifier.eissn1099-1077
dc.contributor.departmentUniversity of Bedfordshireen_US
dc.contributor.departmentAnglia Ruskin Universityen_US
dc.contributor.departmentSwansea University Medical Schoolen_US
dc.identifier.journalHuman Psychopharmacology: Clinical and Experimentalen_US
dc.date.updated2023-10-19T09:23:40Z
dc.description.notegold oa through Wiley agreement
refterms.dateFOA2023-10-19T09:28:05Z


Files in this item

Thumbnail
Name:
HumanPsychopharmacology-2023-S ...
Size:
885.6Kb
Format:
PDF
Description:
final published version

This item appears in the following Collection(s)

Show simple item record

Yellow - can archive pre-print (ie pre-refereeing)
Except where otherwise noted, this item's license is described as Yellow - can archive pre-print (ie pre-refereeing)